American Well (NYSE: AMWL) reported Q2 2025 results, with GAAP revenue of $70.9 million surpassing estimates by 11.7%. Adjusted EBITDA loss improved to $(4.7 million), a significant improvement from Q2 2024. Full-year revenue guidance was lowered to $245-$250 million. The company’s core Converge platform drove growth, with subscription revenue reaching $40.4 million. Strategic client wins and a Defense Health Agency contract extension were highlights. Visit volumes declined to 1.2 million. Guidance for FY2025 includes a narrower adjusted EBITDA loss range. Subscription revenue is expected to account for nearly 60% of total revenue in 2025.

Read more at Nasdaq: American Well (AMWL) Q2 Revenue Up 13%